Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Pharmacology and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0163-7258(92)90027-WPMID 1287673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line

  2007cited by this paper
• Tumor Necrosis Factor a Induces Apoptosis in Mammary Adenocarcinoma Cells by an Increase in Intranuclear Free Ca2+ Concentration and DNA Fragmentation1

  2006cited by this paper
• Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine

  2005cited by this paper
• Rb+ influxes differentiate between growth arrest of cells by different agents

  2005cited by this paper
• Differentiation between serum stimulation of ouabain-resistant and sensitive Rb influx in quiescent NIH 3T3 cells

  2005cited by this paper
• Nitrogen mustard interference with potassium transport systems in Ehrlich ascites tumor cells

  2004cited by this paper
• The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278

  2004cited by this paper
• Resistance to cytostatic drugs at the cellular level

  2004cited by this paper
• Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines

  2004cited by this paper
• Cisplatin nephrotoxicity

  2004cited by this paper
• The New Anticancer Drug Ilmofosine Enhances the Activity of CIS-Platin and Reverses Multidrug Resistance

  1993cited by this paper
• Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.

  1992cited by this paper
• Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA.

  1992cited by this paper
• Intra-arterial induction chemotherapy for soft tissue sarcomas.

  1992cited by this paper
• Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.

  1992cited by this paper
• Lipophilic cations: a group of model substrates for the multidrug-resistance transporter.

  1992cited by this paper
• Role of protein kinase C and the Na+/H+ antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3.

  1992cited by this paper
• Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.

  1992cited by this paper
• Inhibition of breast cancer growth by suramin.

  1992cited by this paper
• The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.

  1992cited by this paper
• Combined treatment of metastatic melanoma with interferons and cytotoxic drugs.

  1992cited by this paper
• Altered cell volume regulation in ras oncogene expressing NIH fibroblasts

  1992cited by this paper
• SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.

  1992cited by this paper
• Interferons: pleiotropic cellular modulators.

  1992cited by this paper
• Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.

  1992cited by this paper
• DNA damage-induced gene expression: signal transduction and relation to growth factor signaling.

  1992cited by this paper
• Effects of suramin on in vitro growth of fresh human tumors.

  1992cited by this paper
• Effects of interferons on the expression of the proto‐oncogene her‐2 in human ovarian carcinoma cells

  1992cited by this paper
• cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway.

  1992cited by this paper
• Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and oncology.

  1992cited by this paper
• Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells.

  1992cited by this paper
• Suramin, an active nonhormonal cytotoxic drug for treatment of prostate cancer: compelling reasons for testing in patients with hormone-refractory breast cancer.

  1992cited by this paper
• Serine/threonine kinases in the propagation of the early mitogenic response.

  1992cited by this paper
• Aflatoxin-transformed C3H/10T1/2 cells overexpress protein kinase C and have an altered response to phorbol ester treatments.

  1992cited by this paper
• The interferon system. A bird's eye view of its biochemistry.

  1992cited by this paper
• Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum(II).

  1992cited by this paper
• Cytokine modulation of cell growth and role in tumour therapy.

  1992cited by this paper
• Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay.

  1992cited by this paper
• Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness.

  1992cited by this paper
• Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.

  1992cited by this paper
• Cell death by apoptosis and its protective role against disease.

  1992cited by this paper
• Hodgkin's disease in 92 patients with HIV infection: The Italian experience

  1992cited by this paper
• Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.

  1992cited by this paper
• Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.

  1992cited by this paper
• Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy

  1992cited by this paper
• Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.

  1992cited by this paper
• Stimulation of K+ transport systems by Ha-ras.

  1991cited by this paper
• Enhancement of the Antiproliferative Effect of cis-Diamminedichloroplatinum (II) and Other Antitumor Agents by Inhibitors of Enzymes Involved in Growth Factor Signal-Transduction

  1991cited by this paper
• Signalling targets for anticancer drug development.

  1991cited by this paper
• The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation.

  1991cited by this paper
• New Insights About the Interaction of Cisplatinum with Intracellular Components

  1991cited by this paper
• Signal Transduction Pathway Regulation of DDP Sensitivity

  1991cited by this paper
• Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin.

  1991cited by this paper
• Complexities of the Protein Kinase C Pathway

  1991cited by this paper
• Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine.

  1991cited by this paper
• In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.

  1991cited by this paper
• Hexadecylphosphocholine: Preclinical and the first clinical results of a new antitumor drug

  1991cited by this paper
• Growth factor and oncogene signalling pathways as targets for rational anticancer drug development.

  1991cited by this paper
• Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells.

  1991cited by this paper
• Activation of a Genetic Program for Cell Death

  1991cited by this paper
• Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity.

  1991cited by this paper
• The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

  1991cited by this paper
• Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.

  1991cited by this paper
• Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells

  1991cited by this paper
• Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.

  1991cited by this paper
• Introduction: Cisplatin update

  1991cited by this paper
• Transmembrane signalling by interferon-α

  1991cited by this paper
• Growth factors and cancer.

  1991cited by this paper
• Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35.

  1991cited by this paper
• Ras C-terminal processing enzymes--new drug targets?

  1991cited by this paper
• Transmembrane signalling by interferon-alpha.

  1991cited by this paper
• Do second messengers play a role in interferon signal transduction?

  1991cited by this paper
• Intracellular particle dissolution in alveolar macrophages.

  1991cited by this paper
• Growth factors in development, transformation, and tumorigenesis.

  1991cited by this paper
• Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity.

  1991cited by this paper
• Membrane-interactive lipids as experimental anticancer drugs.

  1991cited by this paper
• RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages.

  1991cited by this paper
• Tumor necrosis factor Characterization at the molecular, cellular and in vivo level

  1991cited by this paper
• P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

  1991cited by this paper
• [Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo

  1991cited by this paper
• Protein kinase C activation by anthracyclines in swiss 3T3 cells

  1991cited by this paper
• The cell membrane as a target for cancer chemotherapy.

  1991cited by this paper
• Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

  1991cited by this paper
• Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

  1991cited by this paper
• Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.

  1991cited by this paper
• Effect of combination treatment with analogs of luteinizing hormone‐releasing hormone (LH‐RH) or somatostatin and 5‐fluorouracil on pancreatic cancer in hamsters

  1991cited by this paper
• The use of interferon in renal cell carcinoma.

  1991cited by this paper
• [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.

  1991cited by this paper
• Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• B‐859‐35, a new drug with anti‐tumor activity reverses multi‐drug resistance

  1991cited by this paper
• Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.

  1991cited by this paper
• Cisplatin resistance in human cancers.

  1991cited by this paper
• Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.

  1991cited by this paper
• Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat.

  1991cited by this paper
• Suramin inhibits growth of human osteosarcoma xenografts in nude mice.

  1991cited by this paper
• Cisplatin update.

  1991cited by this paper
• Doxorubicin interactions at the membrane: evidence for a biphasic modulation of inositol lipid metabolism.

  1991cited by this paper
• Membrane-interactive lipids as experimental anticancer drugs.

  1991cited by this paper

• Ellagic acid modulates cisplatin toxicity in DMH induced colorectal cancer: Studies on membrane alterations

  2022cites this paper
• Activating drugs with sound: Mechanisms behind sonodynamic therapy and the role of nanomedicine.

  2020cites this paper
• The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.

  2020cites this paper
• Alkylphospholipids are Signal Transduction Modulators with Potential for Anticancer Therapy.

  2019cites this paper
• In vitro effects of benzimidazole/thioether-copper complexes with antitumor activity on human erythrocytes.

  2018cites this paper
• Inhibition of tumor proliferation associated with cell cycle arrest caused by extract and fraction from Casearia sylvestris (Salicaceae).

  2014cites this paper
• The Ganglioside GM3 Is Associated with Cisplatin-Induced Apoptosis in Human Colon Cancer Cells

  2014cites this paper
• Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.

  2012cites this paper
• Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines

  2012cites this paper
• Subcellular targets of cisplatin cytotoxicity: an integrated view.

  2012cites this paper
• Cancer esearch cular and Cellular Pathobiology genomic Effects of Cisplatin : Acute Inhibition echanosensitive Transporters and Channels R out Actin Remodeling

  2010cites this paper
• Nongenomic effects of cisplatin: acute inhibition of mechanosensitive transporters and channels without actin remodeling.

  2010cites this paper
• Redistribution of CD95 into the lipid rafts to treat cancer cells?

  2010cites this paper
• The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

  2010cites this paper
• Biotechnical Drugs as Antitumor Agents

  2008cites this paper
• Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage

  2008cites this paper
• Cisplatin cytotoxicity: DNA and plasma membrane targets.

  2008cites this paper
• Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells.

  2007cites this paper
• Role of early plasma membrane events in chemotherapy-induced cell death.

  2005cites this paper
• Alkylphosphocholine-induced production of nitric oxide and tumor necrosis factor α by U 937 cells

  2005cites this paper
• Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomasin vivo andin vitro; use of liposomes

  2004cites this paper
• NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells

  2003cites this paper
• The Anticancer Drug Cytarabine Does not Interact with the Human Erythrocyte Membrane

  2003cites this paper
• Diol- and triol-type ginseng saponins potentiate the apoptosis of NIH3T3 cells exposed to methyl methanesulfonate.

  2002cites this paper
• Biotechnical Drags as Antitumor Agents

  2001cites this paper
• Nutritional Alterations Associated With HIV Infection

  2000cites this paper
• The Anticancer Drug Cisplatin Interacts with the Human Erythrocyte Membrane

  2000cites this paper
• A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.

  1999cites this paper
• Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells

  1999cites this paper
• The Anticancer Drug Chlorambucil Interacts with the Human Erythrocyte Membrane and Model Phospholipid Bilayers

  1999cites this paper
• Pleiotrope Zytostatikaresistenz (Multidrug resistance) und Hochdosischemotherapie

  1998cites this paper
• Multiwavelength videomicrofluorometric study of some human leukemic lymphoblasts: effect of adriamycin on some biological parameter.

  1998cites this paper
• Antineoplastic activity of sterically stabilized alkylphosphocholine liposomes in human breast carcinomas

  1997cites this paper
• Hepatobiliary elimination of cationic drugs: The role of P-glycoproteins and other ATP-dependent transporters

  1997cites this paper
• The synthesis and characterization of new triphenylethylene platinum(II) complexes

  1997cites this paper
• Drug traffic in the hepatobiliary system.

  1996cites this paper
• Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line.

  1996cites this paper
• Ergot alkaloid glycosides with immunomodulatory activities.

  1996cites this paper
• Alkylphosphocholines and Alkylphosphocholine Liposomes

  1995cites this paper
• Active Cell Death and Cancer

  1995cites this paper
• Synthesis and in vitro biological evaluation of new triphenylethylene platinum (II) complexes

  1995cites this paper
• Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells.

  1995cites this paper
• Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport.

  1995cites this paper
• Active cell death: role in hepatocarcinogenesis and subtypes.

  1994cites this paper
• New Approaches in Cancer Pharmacology: Drug Design and Development

  1994cites this paper
• Synthesis and evaluation of antibody-albumin-methotrexate ternary conjugates for cancer treatment.

  1994cites this paper
• The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance

  1994cites this paper
• Apoptosis and Cancer Therapy

  1994cites this paper
• P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells

  1994cites this paper